Pulmonary emboli missed by CT angiography may be detected by computer aided detection programs.
Pulmonary embolism-computer aided detection (PE-CADx) was able to correctly identify 77.4 percent of cases of acute PE that were previously missed in clinical practice, according to a study published in the American Journal of Roentgenology.
Researchers from the University of Maryland School of Medicine in Baltimore undertook a retrospective study to assess the use of a PE-CADx program in the detection of pulmonary emboli that may have been missed in clinical practice.
A total of 6,769 pulmonary CT angiography (CTA) studies performed between January 2009 and July 2012 were identified for the study and assessed by a thoracic radiologist. When studies positive for PE were identified, all prior contrast-enhanced CTA studies were reviewed. Three thoracic radiologists assessed the presence, proximal extent, and number of PEs.
Studies with missed acute PE and available slice thickness of 2 mm or less were assessed with a prototype PE-CADx program. False-positive PE-CADx marks were analyzed. Outcomes of missed acute PEs were assessed in patients with both follow-up imaging and clinical data.
The researchers found that 53 studies with overlooked PE fit the inclusion criteria for PE-CADx assessment. The program then found at least one PE in 41 of the 53 cases (77.4 percent). Using PE-CADx, the radiologists correctly marked at least one PE all cases where there were multiple PEs (23 of 23) and 18 of 30 (60 percent) cases with a solitary PE.
The PE-CADx per-study sensitivity was significantly higher for segmental (65.5 percent) than for subsegmental (91.7 percent) PEs. PE-CADx averaged 3.8 false-positive marks per case (range, 0–23 marks). Fourteen patients with missed PE who were not receiving anticoagulation therapy developed new PEs, including nine with an isolated subsegmental PE on the initial CT scan.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.